39 related articles for article (PubMed ID: 2379171)
1. Oxygen microbubbles improve radiotherapy tumor control in a rat fibrosarcoma model - A preliminary study.
Fix SM; Papadopoulou V; Velds H; Kasoji SK; Rivera JN; Borden MA; Chang S; Dayton PA
PLoS One; 2018; 13(4):e0195667. PubMed ID: 29630640
[TBL] [Abstract][Full Text] [Related]
2. The effect of hypofractionated radiation and magnetic nanoparticle hyperthermia on tumor immunogenicity and overall treatment response.
Hoopes PJ; Wagner RJ; Song A; Osterberg B; Gladstone DJ; Bursey AA; Fiering SN; Giustini AJ
Proc SPIE Int Soc Opt Eng; 2017; 10066():. PubMed ID: 29515284
[TBL] [Abstract][Full Text] [Related]
3. The Radiation Stress Response: Of the People, By the People and For the People.
Coleman CN
Radiat Res; 2017 Feb; 187(2):129-146. PubMed ID: 28118117
[TBL] [Abstract][Full Text] [Related]
4. Vascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.
Griffin RJ; Williams BW; Koonce NA; Bischof JC; Song CW; Asur R; Upreti M
J Oncol; 2012; 2012():934918. PubMed ID: 22272199
[TBL] [Abstract][Full Text] [Related]
5. Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.
Kusumoto T; Maehara Y; Emi Y; Sakaguchi Y; Baba H; Sakaguchi M; Sugimachi K
Cancer Chemother Pharmacol; 1993; 31(6):455-8. PubMed ID: 8453684
[TBL] [Abstract][Full Text] [Related]
6. The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.
Skarsgard LD; Skwarchuk MW; Vinczan A; Chaplin DJ
Br J Cancer; 1993 Oct; 68(4):681-3. PubMed ID: 8398693
[TBL] [Abstract][Full Text] [Related]
7. Oxygenation of tumors by a hemoglobin solution.
Teicher BA; Schwartz GN; Alvarez Sotomayor E; Robinson MF; Dupuis NP; Menon K
J Cancer Res Clin Oncol; 1993; 120(1-2):85-90. PubMed ID: 8270614
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and drug resistance.
Teicher BA
Cancer Metastasis Rev; 1994 Jun; 13(2):139-68. PubMed ID: 7923547
[TBL] [Abstract][Full Text] [Related]
9. Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
Teicher BA; Herman TS; Hopkins RE; Menon K
J Cancer Res Clin Oncol; 1992; 118(2):123-8. PubMed ID: 1735732
[TBL] [Abstract][Full Text] [Related]
10. The relevance of tumour pH to the treatment of malignant disease.
Wike-Hooley JL; Haveman J; Reinhold HS
Radiother Oncol; 1984 Dec; 2(4):343-66. PubMed ID: 6097949
[TBL] [Abstract][Full Text] [Related]
11. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.
Brown JM
Br J Cancer; 1993 Jun; 67(6):1163-70. PubMed ID: 8512801
[TBL] [Abstract][Full Text] [Related]
12. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
Herman TS; Teicher BA; Coleman CN
Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
[TBL] [Abstract][Full Text] [Related]
13. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
Holden SA; Teicher BA; Herman TS
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
[TBL] [Abstract][Full Text] [Related]
14. Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole.
Teicher BA; Herman TS; Holden SA
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):723-31. PubMed ID: 1825994
[TBL] [Abstract][Full Text] [Related]
15. Combined modality therapy with bleomycin, hyperthermia, and radiation.
Teicher BA; Herman TS; Holden SA
Cancer Res; 1988 Nov; 48(22):6291-7. PubMed ID: 2460220
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
